Wealth Enhancement Trust Services’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-128
Closed -$11.1K – 957
2026
Q2
$11.1K Buy
+128
New +$7.73K ﹤0.01% 715

Other funds holding CORT

Wealth Enhancement Trust Services's CORT Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Corcept Therapeutics (CORT) in Q3 2026, closing a stake of 128 shares — an estimated $11.1K sold.

Wealth Enhancement Trust Services first reported a position in CORT in Q2 2026 and held it in 1 quarter. The position peaked at $11.1K in Q2 2026. 487 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Corcept Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 128 Corcept Therapeutics shares in Q3 2026, an estimated $11.1K.
  • Wealth Enhancement Trust Services first reported a position in Corcept Therapeutics in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's Corcept Therapeutics position peaked at $11.1K in Q2 2026.
  • 487 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.